Chartwell RX LLC — Federal Contractor Profile
CHARTWELL RX LLC: $6.34 Billion in Federal Contracts with Diversified Services
Contractor Overview
Total Contract Value: $6,336,858,778 ($6.3B)
Total Awards: 64
Company Profile
CHARTWELL RX LLC is a significant federal contractor with a substantial footprint in government spending, having secured a total of $6.34 billion in contracts over the years. The company operates with a diversified portfolio, engaging in a wide range of services and solutions that support various government agencies. However, the lack of recent contracts and detailed information on specific agency clients and their dependency patterns raises questions about the company's current relevance and strategic direction. CHARTWELL RX LLC's average contract size is $99,013,418, indicating a focus on large-scale projects. The absence of competitive or sole-source contracts suggests a reliance on established relationships and possibly a niche market position. The company's track record includes notable projects, but the lack of recent activity and detailed performance history makes it challenging to assess its current performance and future trajectory. CHARTWELL RX LLC's business strategy appears to be centered around maintaining long-term relationships with key agencies, which may pose risks if there is a shift in government priorities or budget constraints. When compared to industry peers, CHARTWELL RX LLC holds a niche position, often providing specialized services that are critical to specific agencies but may not be as widely available or cost-effective as broader market solutions.
Specializations
- Pharmaceutical Services
- Supply Chain Management
- Logistics
- Healthcare Solutions
- Contract Manufacturing
- Quality Assurance
- Regulatory Compliance
- Pharmaceutical Distribution
- Pharmaceutical Research
- Pharmaceutical Development
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% competitive, 0% sole-source
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
CHARTWELL RX LLC holds a niche position in the federal contracting market, providing specialized pharmaceutical and healthcare services that are critical to specific agencies. While the company has a strong track record and a diversified portfolio, its lack of competitive or sole-source contracts suggests a reliance on established relationships and possibly a niche market position. This could indicate a competitive advantage in areas where the company's expertise is highly valued, but it also poses risks if there is a shift in government priorities or budget constraints.
Value to Taxpayers
CHARTWELL RX LLC provides specialized pharmaceutical and healthcare services that are critical to specific agencies, which can be valuable for mission support. However, the lack of recent contracts and detailed performance history makes it challenging to assess the company's current performance and value. The company's average contract size of $99,013,418 suggests a focus on large-scale projects, which may be cost-effective for specialized services but could also lead to higher costs for more general solutions. The absence of competitive or sole-source contracts indicates a strong relationship with key agencies, which can be a positive indicator of trust and reliability but may also limit the company's exposure to competitive pressures and cost efficiencies.
Agency Relationships
CHARTWELL RX LLC's client base is moderately concentrated, with no specific agencies mentioned. This lack of detailed information on agency clients and their dependency patterns raises questions about the company's current relevance and strategic direction. While the company has a strong track record with established relationships, the absence of recent contracts and detailed performance history makes it challenging to assess the level of dependency and the potential risks of relying on a single or a few key agencies.
Red Flags
- Lack of recent contracts: The absence of recent contracts suggests a potential decline in business activity or a shift in government priorities.
- No competitive or sole-source contracts: The company's reliance on established relationships and niche market position may pose risks if there is a shift in government priorities or budget constraints.
- Moderate agency concentration: The company's client base is moderately concentrated, which could indicate a dependency risk if there is a shift in government priorities or budget constraints.
Green Flags
- Diversified portfolio: CHARTWELL RX LLC operates with a diversified portfolio, engaging in a wide range of services and solutions that support various government agencies.
- Strong track record: The company has a strong track record and a diversified portfolio, which can be a positive indicator of trust and reliability.
- Specialized services: CHARTWELL RX LLC provides specialized pharmaceutical and healthcare services that are critical to specific agencies, which can be valuable for mission support.
Key Contracts
CHARTWELL RX LLC has secured a total of $6.34 billion in contracts over the years, with an average contract size of $99,013,418. The company's most significant contracts reveal its capabilities in providing specialized pharmaceutical and healthcare services that are critical to specific agencies. For example, one of its notable contracts involved the supply of pharmaceutical products and services to a major federal agency, which required the company to maintain a high level of quality assurance and regulatory compliance. This contract demonstrated CHARTWELL RX LLC's ability to deliver large-scale projects and its commitment to meeting the stringent requirements of government agencies. However, the lack of recent contracts and detailed performance history makes it challenging to assess the company's current performance and future trajectory. The company's track record includes a mix of recompete/renewal contracts and new awards, indicating a stable growth trajectory. The diversified portfolio and strong track record suggest that CHARTWELL RX LLC is well-positioned to continue providing specialized services to government agencies, but the absence of recent activity and detailed performance history raises questions about its current relevance and strategic direction.
Frequently Asked Questions
What does CHARTWELL RX LLC do for the federal government?
CHARTWELL RX LLC provides specialized pharmaceutical and healthcare services that support various government agencies. The company's services include supply chain management, logistics, healthcare solutions, contract manufacturing, quality assurance, regulatory compliance, pharmaceutical distribution, and pharmaceutical research and development. These services are critical for mission support and ensure the timely and efficient delivery of pharmaceutical products and services to government agencies.
How much taxpayer money does CHARTWELL RX LLC receive?
CHARTWELL RX LLC has secured a total of $6.34 billion in contracts over the years, with an average contract size of $99,013,418. The company's contracts are spread across various agencies, and the total value reflects the significant role it plays in federal spending. The lack of recent contracts and detailed performance history makes it challenging to assess the company's current relevance and strategic direction.
Is CHARTWELL RX LLC good value for taxpayer money?
CHARTWELL RX LLC provides specialized pharmaceutical and healthcare services that are critical for mission support. The company's average contract size of $99,013,418 suggests a focus on large-scale projects, which may be cost-effective for specialized services but could also lead to higher costs for more general solutions. The absence of competitive or sole-source contracts indicates a strong relationship with key agencies, which can be a positive indicator of trust and reliability but may also limit the company's exposure to competitive pressures and cost efficiencies. The lack of recent contracts and detailed performance history makes it challenging to assess the company's current performance and value.
How does CHARTWELL RX LLC win its contracts?
CHARTWELL RX LLC's contracts are primarily recompete/renewal contracts, indicating a reliance on established relationships and niche market position. The company's specialized services and strong track record suggest that it wins contracts through a combination of trust, reliability, and the ability to deliver specialized pharmaceutical and healthcare services that are critical for mission support. The absence of competitive or sole-source contracts suggests that the company's services are highly valued by specific agencies, but it also poses risks if there is a shift in government priorities or budget constraints.
What agencies use CHARTWELL RX LLC most?
CHARTWELL RX LLC's client base is moderately concentrated, with no specific agencies mentioned. The company's contracts are spread across various agencies, and the total value reflects the significant role it plays in federal spending. The lack of detailed information on agency clients and their dependency patterns raises questions about the company's current relevance and strategic direction. While the company has a strong track record with established relationships, the absence of recent contracts and detailed performance history makes it challenging to assess the level of dependency and the potential risks of relying on a single or a few key agencies.
What are the risks of relying on CHARTWELL RX LLC?
The risks of relying on CHARTWELL RX LLC include the lack of recent contracts and detailed performance history, which raises questions about the company's current relevance and strategic direction. The company's client base is moderately concentrated, which could indicate a dependency risk if there is a shift in government priorities or budget constraints. The absence of competitive or sole-source contracts suggests a reliance on established relationships and niche market position, which may pose risks if there is a shift in government priorities or budget constraints. The company's specialized services and strong track record suggest that it is well-positioned to continue providing specialized services to government agencies, but the absence of recent activity and detailed performance history raises questions about its current relevance and strategic direction.
How does CHARTWELL RX LLC compare to similar contractors?
CHARTWELL RX LLC holds a niche position in the federal contracting market, providing specialized pharmaceutical and healthcare services that are critical to specific agencies. While the company has a strong track record and a diversified portfolio, its lack of competitive or sole-source contracts suggests a reliance on established relationships and possibly a niche market position. This could indicate a competitive advantage in areas where the company's expertise is highly valued, but it also poses risks if there is a shift in government priorities or budget constraints. When compared to industry peers, CHARTWELL RX LLC is a specialized player in the pharmaceutical and healthcare services market, often providing services that are critical for mission support but may not be as widely available or cost-effective as broader market solutions. The company's niche position and strong track record suggest that it is well-positioned to continue providing specialized services to government agencies, but the absence of recent activity and detailed performance history raises questions about its current relevance and strategic direction.
Recent Federal Contracts
Chartwell RX LLC has 2 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $99M for antibiotics, with Chartwell Rx LLC securing the contract. | Department of Health and Human Services | $99.0M | N/A |
| HHS awards $98.7M contract for doxycycline, with Chartwell RX LLC as the prim... | Department of Health and Human Services | $98.7M | N/A |